These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32035665)

  • 1. Poly- and perfluoroalkyl substances in maternal serum: Method development and application in Pilot Study of the Japan Environment and Children's Study.
    Nakayama SF; Isobe T; Iwai-Shimada M; Kobayashi Y; Nishihama Y; Taniguchi Y; Sekiyama M; Michikawa T; Yamazaki S; Nitta H; Oda M; Mitsubuchi H; Sanefuji M; Ohga S; Mise N; Ikegami A; Suga R; Shimono M
    J Chromatogr A; 2020 May; 1618():460933. PubMed ID: 32035665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health.
    Itoh S; Araki A; Mitsui T; Miyashita C; Goudarzi H; Sasaki S; Cho K; Nakazawa H; Iwasaki Y; Shinohara N; Nonomura K; Kishi R
    Environ Int; 2016 Sep; 94():51-59. PubMed ID: 27209000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of perfluorooctanoic acid and perfluorooctanesulfonic acid in Korean sera using LC-MS/MS.
    Heo DG; Lee DC; Kwon YM; Seol MJ; Moon JS; Chung SM; Kim JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123138. PubMed ID: 35114474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectrometry.
    Salihovic S; Kärrman A; Lindström G; Lind PM; Lind L; van Bavel B
    J Chromatogr A; 2013 Aug; 1305():164-70. PubMed ID: 23891383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Richardson DB; Baird DD; Haug LS; Stuebe AM; Klungsøyr K; Harmon Q; Becher G; Thomsen C; Sabaredzovic A; Eggesbø M; Hoppin JA; Travlos GS; Wilson RE; Trogstad LI; Magnus P; Longnecker MP
    Am J Epidemiol; 2014 Apr; 179(7):824-33. PubMed ID: 24557813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6-11 years.
    Jain RB; Ducatman A
    Environ Pollut; 2018 Dec; 243(Pt A):1-8. PubMed ID: 30170203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new on-line SPE LC-HRMS method for the analysis of Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) in PM
    Kourtchev I; Hellebust S; Heffernan E; Wenger J; Towers S; Diapouli E; Eleftheriadis K
    Sci Total Environ; 2022 Aug; 835():155496. PubMed ID: 35483471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid method for the detection and quantification of legacy and emerging per- and polyfluoroalkyl substances (PFAS) in bird feathers using UPLC-MS/MS.
    Groffen T; Bervoets L; Jeong Y; Willems T; Eens M; Prinsen E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 May; 1172():122653. PubMed ID: 33839488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pregnancy on the levels of selected perfluoroalkyl compounds for females aged 17-39 years: data from National Health and Nutrition Examination Survey 2003-2008.
    Jain RB
    J Toxicol Environ Health A; 2013; 76(7):409-21. PubMed ID: 23611181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
    Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
    Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends of perfluorinated alkyl acids in serum from Danish pregnant women 2008-2013.
    Bjerregaard-Olesen C; Bach CC; Long M; Ghisari M; Bossi R; Bech BH; Nohr EA; Henriksen TB; Olsen J; Bonefeld-Jørgensen EC
    Environ Int; 2016 May; 91():14-21. PubMed ID: 26891270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a solid-phase extraction-HPLC/single quadrupole MS method for quantification of perfluorochemicals in whole blood.
    Kärrman A; van Bavel B; Järnberg U; Hardell L; Lindström G
    Anal Chem; 2005 Feb; 77(3):864-70. PubMed ID: 15679355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal trends of per- and polyfluoroalkyl substances in children's serum.
    Koponen J; Winkens K; Airaksinen R; Berger U; Vestergren R; Cousins IT; Karvonen AM; Pekkanen J; Kiviranta H
    Environ Int; 2018 Dec; 121(Pt 1):591-599. PubMed ID: 30308470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
    Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
    J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children's exposure to perfluoroalkyl acids - a modelling approach.
    Balk FGP; Winkens Pütz K; Ribbenstedt A; Gomis MI; Filipovic M; Cousins IT
    Environ Sci Process Impacts; 2019 Nov; 21(11):1875-1886. PubMed ID: 31549993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.